LUXIANGYI DL-8M High-Capacity Refrigerated Centrifuge

Overview

The LUXIANGYI DL-8M High-Capacity Refrigerated Centrifuge is an engineered solution for high-throughput, temperature-sensitive separation tasks in blood banking, biopharmaceutical manufacturing, and large-scale cell culture processing. Designed around a robust floor-standing architecture, it employs a high-torque AC frequency-controlled motor to deliver stable rotational dynamics at speeds up to 8,000 rpm — generating a maximum relative centrifugal force (RCF) of 11,260 × g. Its core operational principle relies on sedimentation-based separation under controlled thermal conditions: the refrigeration system maintains sample integrity during extended runs by actively regulating chamber temperature between −20 °C and +40 °C with ±1 °C accuracy. The unit utilizes R404a refrigerant — a globally accepted, non-ozone-depleting alternative compliant with current environmental directives — and integrates an imported high-efficiency compressor assembly to ensure consistent cooling performance even under full-load operation. Unlike benchtop or microcentrifuge platforms, the DL-8M is purpose-built for batch processing of volume-intensive biological matrices such as whole blood, plasma, fermentation broths, and clarified lysates.

Key Features

• High-capacity horizontal rotor configuration supporting up to six 2,400 mL bottles per run — enabling single-batch processing of up to 14,400 mL of sample volume, making it one of the highest-capacity refrigerated centrifuges certified for routine clinical and industrial use in China.
• Microprocessor-based control system with digital interface (DL-8M) or optional large LCD panel (DL-8MS), allowing precise parameter entry, real-time rpm/RCF conversion, and automatic storage of up to 10 user-defined protocols.
• Programmable acceleration and deceleration profiles: 10 distinct ramp curves permit optimization of shear-sensitive separations — critical when handling fragile cells, viral vectors, or extracellular vesicles.
• Comprehensive safety architecture including electromagnetic door interlock, real-time imbalance monitoring, overspeed cutoff, overtemperature shutdown, and self-diagnostic fault reporting — all aligned with IEC 61010-2-020 requirements for laboratory centrifuges.
• Acoustically damped mechanical design achieving <70 dB(A) noise emission at rated speed — suitable for installation in shared laboratory environments without dedicated acoustic enclosures.

Sample Compatibility & Compliance

The DL-8M accommodates standard and custom-configured horizontal rotors compatible with common clinical and industrial containers: triple-bag blood sets (up to 12 × 400 mL units), 500 mL conical tubes, 2,000 mL and 2,400 mL wide-mouth bottles, and adaptable inserts for 50 mL, 100 mL, and 250 mL vessels. Its structural design supports GMP-aligned workflows through traceable parameter logging (where paired with DL-8MS and optional data export module) and adherence to ISO 13485-relevant mechanical safety benchmarks. While not FDA 21 CFR Part 11–validated out-of-the-box, the system’s programmable parameters, audit-ready error logs, and reproducible rotor performance make it suitable for GLP-compliant method development and QC release testing in regulated biomanufacturing settings.

Software & Data Management

The DL-8M operates via embedded firmware without external PC dependency. All run parameters — including speed, time, temperature, acceleration/deceleration rate, and rotor identification — are stored locally upon completion. The digital interface displays real-time RCF calculation synchronized with set rpm values, eliminating manual conversion errors. Optional RS-232 or USB connectivity (available on select configurations) enables export of run records in CSV format for integration into LIMS or electronic lab notebooks. Firmware updates are performed via secure USB key, ensuring version control and regulatory traceability during equipment lifecycle management.

Applications

• Blood component separation in regional blood centers: efficient harvesting of platelet-rich plasma (PRP), buffy coat, and red blood cell concentrates from pooled donations.
• Downstream processing in biologics production: clarification of mammalian cell culture harvests, recovery of inclusion bodies, and concentration of monoclonal antibody intermediates.
• Vaccine manufacturing support: pelleting of bacterial or yeast cells, purification of virus-like particles (VLPs), and cold-chain-compatible centrifugation of adjuvant formulations.
• Environmental microbiology: high-volume water sample processing for pathogen concentration prior to molecular detection.
• Academic core facilities: scalable centrifugation for proteomics sample prep, organelle isolation, and extracellular RNA enrichment from biofluids.

FAQ

What is the maximum allowable imbalance tolerance for safe operation?
The DL-8M detects mass asymmetry exceeding 50 g per rotor position and halts rotation immediately to prevent mechanical stress.
Can this centrifuge be used for continuous operation over multiple shifts?
Yes — its industrial-grade compressor, reinforced drive shaft, and thermally managed motor housing support uninterrupted operation up to 99 hours 59 minutes per cycle.
Is rotor calibration required before first use?
Each rotor is factory-balanced and supplied with individual serial-numbered certification; no field recalibration is necessary unless physical damage occurs.
Does the system meet CE or UL safety standards?
The DL-8M complies with IEC 61010-1 and IEC 61010-2-020; CE marking is available upon request for EU-market configurations.
How is temperature uniformity verified across the chamber?
Independent validation reports confirm ±1.5 °C spatial variation across the full 2,400 mL rotor cavity at −10 °C operating point, measured per ISO/IEC 17025-accredited procedures.